QPBE
REGN icon

Quintet Private Bank (Europe)’s Regeneron Pharmaceuticals REGN Stock Holding History

Quintet Private Bank (Europe)’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$62.4K Hold
100
– – ﹤0.01% 136
2026
Q1 		$77.3K Buy
+100
New +$76.6K 0.01% 134

Other funds holding REGN

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
MCI
McDonald Capital Investors Orinda, California $1.37B AUM 1.88% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Retirement Systems of Alabama
Retirement Systems of Alabama Montgomery, Alabama $33.2B AUM 38.15% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
GA
GuoLine Advisory Singapore $1.07B AUM 26.27% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
BS
Banco Santander Madrid, Spain $16.1B AUM 35.02% 1-Year Est. Return

Quintet Private Bank (Europe)'s REGN Position: Q2 2026 in Review

Quintet Private Bank (Europe) held its Regeneron Pharmaceuticals (REGN) position steady in Q2 2026 at 100 shares worth $62.4K. The position accounts for ﹤0.01% of the portfolio, ranked #136.

Quintet Private Bank (Europe) first reported a position in REGN in Q1 2026 and has held it in 2 quarters since. The position peaked at $77.3K in Q1 2026. 416 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

  • Quintet Private Bank (Europe) held 100 shares of Regeneron Pharmaceuticals worth $62.4K as of Q2 2026.
  • Quintet Private Bank (Europe) left its Regeneron Pharmaceuticals share count unchanged in Q2 2026.
  • Regeneron Pharmaceuticals made up ﹤0.01% of Quintet Private Bank (Europe)'s portfolio in Q2 2026, its #136 holding.
  • Quintet Private Bank (Europe) first reported a position in Regeneron Pharmaceuticals in Q1 2026 and has held it in 2 quarters since.
  • Quintet Private Bank (Europe)'s Regeneron Pharmaceuticals position peaked at $77.3K in Q1 2026.
  • 416 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on Quintet Private Bank (Europe)'s 13F filing for Q2 2026, filed 13 Jul 2026.